Please respond to the Gen-ART review. I agree with the Gen-ART reviewer that the reference to the SUIT working group in Section 1.1 should be removed.

Thanks for the work that went into creating this document. I have no
comments on its contents (the crypto is somewhat outside my area of
expertise), although I have a few observations regarding the examples.

---------------------------------------------------------------------------

Appendix A:

>  This appendix provides a non-normative example of a COSE full message
>  signature and an example of a COSE_Sign1 message.  This section
>  follows the formatting used in [RFC8152].

I would suggest that RFC 8610 might be a better reference here, as it is
the document that actually defines the extended CBOR diagnostic format.
In particular my recommendation is:

  "This section is formatted according to the extended CBOR diagnostic
   format defined by [RFC8610]."

---------------------------------------------------------------------------

§A.1:

>  98(
>    [
>      / protected / h'a10300' / {
>          \ content type \ 3:0
>        } / ,
>      / unprotected / {},
>      / payload / 'This is the content.',
>      / signatures / [
>        [
>          / protected / h'a101382d' / {
>              \ alg \ 1:-46 \ HSS-LMS \
>            } / ,
>          / unprotected / {
>            / kid / 4:'ItsBig'
>          },
>          / signature / ...
>        ]
>      ]
>    ]
>  )

I think there are two things here that need to be addressed.

First, section 3 of this document specifies:

>     o  The 'kty' field MUST be present, and it MUST be 'HSS-LMS'.

I can't find a 'kty' field in this example.

Also, this example uses '-46' as the identifier for HSS-LMS,
while section 6.1 specifies the value as "TBD." This example needs
a clear note added for the RFC editor that the "-46" needs to be
replaced by the IANA-assigned value. A similar annotation will be
required for the 'kty' field, regarding the value assigned for section
6.2.

---------------------------------------------------------------------------

§A.2:

Same comments as A.1, above.